Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Assets (2018 - 2025)

Arcus Biosciences has reported Return on Assets over the past 8 years, most recently at 0.33% for Q4 2025.

  • Quarterly results put Return on Assets at 0.33% for Q4 2025, down 10.0% from a year ago — trailing twelve months through Dec 2025 was 0.33% (down 10.0% YoY), and the annual figure for FY2025 was 0.31%, down 6.0%.
  • Return on Assets for Q4 2025 was 0.33% at Arcus Biosciences, roughly flat from 0.33% in the prior quarter.
  • Over the last five years, Return on Assets for RCUS hit a ceiling of 0.06% in Q3 2022 and a floor of 0.34% in Q1 2025.
  • Median Return on Assets over the past 5 years was 0.22% (2021), compared with a mean of 0.19%.
  • Biggest five-year swings in Return on Assets: surged 38bps in 2022 and later decreased -30bps in 2023.
  • Arcus Biosciences' Return on Assets stood at 0.04% in 2021, then tumbled by -555bps to 0.2% in 2022, then plummeted by -35bps to 0.27% in 2023, then increased by 14bps to 0.23% in 2024, then tumbled by -45bps to 0.33% in 2025.
  • The last three reported values for Return on Assets were 0.33% (Q4 2025), 0.33% (Q3 2025), and 0.27% (Q2 2025) per Business Quant data.